Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 3Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Surgery 1

Interventions

pembrolizumab 550Specimen Handling 462Carboplatin 441Magnetic Resonance Spectroscopy 429Cyclophosphamide 412Cisplatin 398Radiotherapy 313Gemcitabine 310Bevacizumab 306Paclitaxel 294Biopsy 259Drug Therapy 248Capecitabine 241Oxaliplatin 239fludarabine 238Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 202Dexamethasone 186Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 145durvalumab 143Leucovorin 138atezolizumab 137toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interventional × Salpingectomy × Clear all
NCT06312124 2026-01-23

A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
266 enrolled

Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡